Loading…
Reported covered position: Scheduler and other positions, Sen. Richard Burr; Intern, Rep. John Boehner; Intern, Rep. Mike Kelly
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program.
Client: NOVARTIS · Firm: DLA PIPER LLP (US)
Issues relating to drug pricing and drug development policies. Pharmacy benefit manager legislation related to patient access to therapies. H.R. 1492/S. 832, EPIC Act. H.R. 1672, MINI Act. Most Favored Nation (MFN) policy. Issues related to the 340B program.
To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program.
Client: NOVARTIS · Firm: DLA PIPER LLP (US)
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
MICHAELS STORES, INC. via DLA PIPER LLP (US)
2026 · third_quarter · Q3
Policies and proposals related to tariff and trade issues.
Policies and proposals related to tariff and trade issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Source: Senate LDA
| COALITION FOR SMARTER REGULATION OF NICOTINE |
| 7 |
| 2025–2026 |
| ATLANTIC COAST CONFERENCE | 6 | 2025–2026 |
| BIOGEN, INC. | 6 | 2025–2026 |
| LAZARUS AI | 6 | 2024–2025 |
| NOVARTIS | 6 | 2025–2026 |
| UNITED WAY WORLDWIDE | 6 | 2025–2026 |
| ASSOCIATION OF AMERICAN UNIVERSITIES | 5 | 2025–2026 |
| DUKE UNIVERSITY HEALTH SYSTEM | 5 | 2025 |
| SOELECT INC | 5 | 2024 |
| HEAD START CALIFORNIA | 4 | 2025–2026 |
| PARTICULA GROUP INC. | 4 | 2026 |
| HUMACYTE, INC. | 3 | 2024 |
| MICHAELS STORES, INC. | 3 | 2026 |
| Vertanical GmbH | 3 | 2023 |
| ADVOCATE HEALTH | 2 | 2024 |
| PGA TOUR | 2 | 2026 |
| RAI SERVICES COMPANY | 2 | 2023 |
| STAX ENGINEERING, INC. | 2 | 2026 |
| TTX COMPANY | 2 | 2026 |
Issues relating to drug pricing and drug development policies. Pharmacy benefit manager legislation related to patient access to therapies. H.R. 1492/S. 832, EPIC Act. H.R. 1672, MINI Act. Most Favored Nation (MFN) policy.
Issues relating to drug pricing and drug development policies. Pharmacy benefit manager legislation related to patient access to therapies. H.R. 1492/S. 832, EPIC Act. H.R. 1672, MINI Act. Most Favored Nation (MFN) policy.
Issues relating to drug pricing and drug development policies. Pharmacy benefit manager legislation related to patient access to therapies. H.R. 1492/S. 832, EPIC Act. H.R. 1672, MINI Act. Most Favored Nation (MFN) policy. Issues related to the 340B program.
Policy issues related to tokenized assets. H.R. 3633, Digital Asset Market Clarity Act of 2025.
Policy issues related to tokenized assets. H.R. 3633, Digital Asset Market Clarity Act of 2025.
Legislative and regulatory proposals affecting intercollegiate athletics. H.R. 4312, SCORE Act. S. 2932, Student Athlete Fairness and Enforcement Act. S. 4668, Protect College Sports Act.
Policies and proposals impacting higher education for health sciences. Departments of Labor-HHS-Education Appropriations, FY2027, provisions regarding health workforce programming. Federal student aid. H.R. 4312, Student Compensation and Opportunity through Rights and Endorsements Act (SCORE Act).
Legislative and regulatory proposals affecting intercollegiate athletics. H.R. 4312, SCORE Act. S. 2932, Student Athlete Fairness and Enforcement Act.
Policies and proposals impacting higher education for health sciences. H.R. 9260, Departments of Labor-HHS-Education Appropriations, FY2027, provisions regarding health workforce programming. Federal student aid. H.R. 4312, Student Compensation and Opportunity through Rights and Endorsements Act (SCORE Act). S. 4668, Protect College Sports Act.
Legislative and regulatory proposals affecting intercollegiate athletics. H.R. 4312, SCORE Act. S. 2932, Student Athlete Fairness and Enforcement Act. S. 4668, Protect College Sports Act.
Agriculture, Rural Development, Food and Drug Administration, and Related Agency Appropriations Act, 2027
Client: COALITION FOR SMARTER REGULATION OF NICOTINE · Firm: DLA PIPER LLP (US)
Center for Tobacco products oversight. FDA oversight. H.R. 8646, Department of Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY2027, provisions on tobacco.
Agriculture, Rural Development, Food and Drug Administration, and Related Agency Appropriations Act, 2027
Client: COALITION FOR SMARTER REGULATION OF NICOTINE · Firm: DLA PIPER LLP (US)
Center for Tobacco products oversight. FDA oversight. H.R. 8646, Department of Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY2027, provisions on tobacco.
National Defense Authorization Act for Fiscal Year 2027
Client: CROWDSTRIKE, INC. · Firm: DLA PIPER LLP (US)
Policies and proposals related to cybersecurity. H.R. 8800, National Defense Authorization Act, FY 2027, policies and proposals related to cybersecurity.
National Defense Authorization Act for Fiscal Year 2027
Client: DUKE UNIVERSITY · Firm: DLA PIPER LLP (US)
Policies and proposals related to federal research funding. H.R. 8800, National Defense Authorization Act for FY2027, provisions related to conditions for research funding. Federal student aid. S. 4668, Protect College Sports Act of 2026. H.R. 9260, Departments of Labor-HHS-Education Appropriations, FY2027, provisions related to conditions for research funding. Federal student aid.
National Defense Authorization Act for Fiscal Year 2027
Client: DUKE UNIVERSITY · Firm: DLA PIPER LLP (US)
Policies and proposals related to federal research funding. H.R. 8800, National Defense Authorization Act for FY2027, provisions related to conditions for research funding. Federal student aid. S. 4668, Protect College Sports Act of 2026. H.R. 9260, Departments of Labor-HHS-Education Appropriations, FY2027, provisions related to conditions for research funding. Federal student aid. Department of Agriculture/FDA Appropriations, FY2027, provisions related to Centers of Excellence funding.
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027
Client: DUKE UNIVERSITY · Firm: DLA PIPER LLP (US)
Policies and proposals related to federal research funding. H.R. 8800, National Defense Authorization Act for FY2027, provisions related to conditions for research funding. Federal student aid. S. 4668, Protect College Sports Act of 2026. H.R. 9260, Departments of Labor-HHS-Education Appropriations, FY2027, provisions related to conditions for research funding. Federal student aid. Department of Agriculture/FDA Appropriations, FY2027, provisions related to Centers of Excellence funding.
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027
Client: UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL · Firm: DLA PIPER LLP (US)
Policies and proposals impacting higher education for health sciences. H.R. 9260, Departments of Labor-HHS-Education Appropriations, FY2027, provisions regarding health workforce programming. Federal student aid. S. 4668, Protect College Sports Act.
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027
Client: UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL · Firm: DLA PIPER LLP (US)
Policies and proposals impacting higher education for health sciences. H.R. 9260, Departments of Labor-HHS-Education Appropriations, FY2027, provisions regarding health workforce programming. Federal student aid. H.R. 4312, Student Compensation and Opportunity through Rights and Endorsements Act (SCORE Act). S. 4668, Protect College Sports Act.
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027
Client: DUKE UNIVERSITY · Firm: DLA PIPER LLP (US)
Policies and proposals related to federal research funding. H.R. 8800, National Defense Authorization Act for FY2027, provisions related to conditions for research funding. Federal student aid. S. 4668, Protect College Sports Act of 2026. H.R. 9260, Departments of Labor-HHS-Education Appropriations, FY2027, provisions related to conditions for research funding. Federal student aid.
Student Athlete Fairness and Enforcement Act
Client: ATLANTIC COAST CONFERENCE · Firm: DLA PIPER LLP (US)
Legislative and regulatory proposals affecting intercollegiate athletics. H.R. 4312, SCORE Act. S. 2932, Student Athlete Fairness and Enforcement Act.
Student Athlete Fairness and Enforcement Act
Client: ATLANTIC COAST CONFERENCE · Firm: DLA PIPER LLP (US)
Legislative and regulatory proposals affecting intercollegiate athletics. H.R. 4312, SCORE Act. S. 2932, Student Athlete Fairness and Enforcement Act. S. 4668, Protect College Sports Act.
Student Athlete Fairness and Enforcement Act
Client: ATLANTIC COAST CONFERENCE · Firm: DLA PIPER LLP (US)
Legislative and regulatory proposals affecting intercollegiate athletics. H.R. 4312, SCORE Act. S. 2932, Student Athlete Fairness and Enforcement Act. S. 4668, Protect College Sports Act.
Protect College Sports Act of 2026
Client: UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL · Firm: DLA PIPER LLP (US)
Policies and proposals impacting higher education for health sciences. H.R. 9260, Departments of Labor-HHS-Education Appropriations, FY2027, provisions regarding health workforce programming. Federal student aid. S. 4668, Protect College Sports Act.
Policies and proposals related to federal research funding. H.R. 8800, National Defense Authorization Act for FY2027, provisions related to conditions for research funding. Federal student aid. S. 4668, Protect College Sports Act of 2026. H.R. 9260, Departments of Labor-HHS-Education Appropriations, FY2027, provisions related to conditions for research funding. Federal student aid.
Policies and proposals related to federal research funding. H.R. 8800, National Defense Authorization Act for FY2027, provisions related to conditions for research funding. Federal student aid. S. 4668, Protect College Sports Act of 2026. H.R. 9260, Departments of Labor-HHS-Education Appropriations, FY2027, provisions related to conditions for research funding. Federal student aid. Department of Agriculture/FDA Appropriations, FY2027, provisions related to Centers of Excellence funding.
Protect College Sports Act of 2026
Client: UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL · Firm: DLA PIPER LLP (US)
Policies and proposals impacting higher education for health sciences. H.R. 9260, Departments of Labor-HHS-Education Appropriations, FY2027, provisions regarding health workforce programming. Federal student aid. H.R. 4312, Student Compensation and Opportunity through Rights and Endorsements Act (SCORE Act). S. 4668, Protect College Sports Act.
Protect College Sports Act of 2026
Client: ATLANTIC COAST CONFERENCE · Firm: DLA PIPER LLP (US)
Legislative and regulatory proposals affecting intercollegiate athletics. H.R. 4312, SCORE Act. S. 2932, Student Athlete Fairness and Enforcement Act. S. 4668, Protect College Sports Act.
Policies and proposals related to federal research funding. Federal student aid. S. 4668, Protect College Sports Act.
Protect College Sports Act of 2026
Client: ATLANTIC COAST CONFERENCE · Firm: DLA PIPER LLP (US)
Legislative and regulatory proposals affecting intercollegiate athletics. H.R. 4312, SCORE Act. S. 2932, Student Athlete Fairness and Enforcement Act. S. 4668, Protect College Sports Act.
Policies and proposals related to federal research funding. Federal student aid. S. 4668, Protect College Sports Act.
Issues relating to drug pricing and drug development policies. Pharmacy benefit manager legislation related to patient access to therapies. H.R. 1492/S. 832, EPIC Act. H.R. 1672, MINI Act. Most Favored Nation (MFN) policy.
Issues relating to drug pricing and drug development policies. Pharmacy benefit manager legislation related to patient access to therapies. H.R. 1492/S. 832, EPIC Act. H.R. 1672, MINI Act. Most Favored Nation (MFN) policy. Issues related to the 340B program.
A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Environmental Protection Agency relating to "California State Nonroad Engine Pollution Control Standards; Ocean-Going Vessels At-Berth; Notice of Decision".
Client: STAX ENGINEERING, INC. · Firm: DLA PIPER LLP (US)
S.J. Res. 209, A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Environmental Protection Agency relating to "California State Nonroad Engine Pollution Control Standards; Ocean-Going Vessels At-Berth; Notice of Decision"
A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Environmental Protection Agency relating to "California State Nonroad Engine Pollution Control Standards; Ocean-Going Vessels At-Berth; Notice of Decision".
Client: STAX ENGINEERING, INC. · Firm: DLA PIPER LLP (US)
S.J. Res. 209, A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Environmental Protection Agency relating to "California State Nonroad Engine Pollution Control Standards; Ocean-Going Vessels At-Berth; Notice of Decision."
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: DUKE UNIVERSITY · Firm: DLA PIPER LLP (US)
Policies and proposals related to university endowment tax. H.R. 1, One Big Beautiful Bill Act, university endowment tax. Federal Student Aid.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: WAKE FOREST UNIVERSITY · Firm: DLA PIPER LLP (US)
Policies and proposals related to federal research funding. H.R. 1, One Big Beautiful Bill Act, federal student aid.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: WAKE FOREST UNIVERSITY · Firm: DLA PIPER LLP (US)
H.R. 1, One Big Beautiful Bill Act, university endowment tax.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: WAKE FOREST UNIVERSITY · Firm: DLA PIPER LLP (US)
Policies and proposals related to federal research funding. H.R. 1, One Big Beautiful Bill Act, federal student aid.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: WAKE FOREST UNIVERSITY · Firm: DLA PIPER LLP (US)
H.R. 1, One Big Beautiful Bill Act, university endowment tax.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: DUKE UNIVERSITY · Firm: DLA PIPER LLP (US)
Policies and proposals related to university endowment tax. H.R. 1, One Big Beautiful Bill Act, university endowment tax.
To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program.
Client: NOVARTIS · Firm: DLA PIPER LLP (US)
Issues relating to drug pricing and drug development policies. Pharmacy benefit manager legislation related to patient access to therapies. H.R. 1492/S. 832, EPIC Act. H.R. 1672, MINI Act. Most Favored Nation (MFN) policy.
To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program.
Client: NOVARTIS · Firm: DLA PIPER LLP (US)
Issues relating to drug pricing and drug development policies. Pharmacy benefit manager legislation related to patient access to therapies. H.R. 1492/S. 832, EPIC Act. H.R. 1672, MINI Act. Most Favored Nation (MFN) policy.
To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program.
Client: NOVARTIS · Firm: DLA PIPER LLP (US)
Issues relating to drug pricing policy. Pharmacy benefit manager legislation related to patient access to therapies. H.R. 1492/S. 832, EPIC Act. H.R. 1672, MINI Act.
To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program.
Client: BIOGEN, INC. · Firm: DLA PIPER LLP (US)
Issues relating to drug pricing policy. Pharmacy benefit manager legislation related to patient access to therapies. H.R. 1492/S. 832, EPIC Act.
Issues relating to drug pricing and drug development policies. Pharmacy benefit manager legislation related to patient access to therapies. H.R. 1492/S. 832, EPIC Act. H.R. 1672, MINI Act. Most Favored Nation (MFN) policy.
Issues relating to drug pricing policy. Pharmacy benefit manager legislation related to patient access to therapies. H.R. 1492/S. 832, EPIC Act. H.R. 1672, MINI Act.
Issues relating to drug pricing and drug development policies. Pharmacy benefit manager legislation related to patient access to therapies. H.R. 1492/S. 832, EPIC Act. H.R. 1672, MINI Act. Most Favored Nation (MFN) policy.
Streamlining Procurement for Effective Execution and Delivery and National Defense Authorization Act for Fiscal Year 2026
Client: DUKE UNIVERSITY · Firm: DLA PIPER LLP (US)
Policies and proposals related to federal research funding. H.R. 3838/S. 2296, National Defense Authorization Act of FY2026, provisions regarding the DETERRENT Act.
Streamlining Procurement for Effective Execution and Delivery and National Defense Authorization Act for Fiscal Year 2026
Client: ASSOCIATION OF AMERICAN UNIVERSITIES · Firm: DLA PIPER LLP (US)
Research security, research funding, and the importance of American research enterprise and higher education. H.R. 5304/S. 2587, Departments of Labor/HHS/Education Appropriations Act, FY2026, provisions on federal research funding. H.R. 3838/S. 2296, National Defense Authorization Act for FY2026, provisions related to conditions for research funding.
Streamlining Procurement for Effective Execution and Delivery and National Defense Authorization Act for Fiscal Year 2026
Client: DUKE UNIVERSITY · Firm: DLA PIPER LLP (US)
Policies and proposals related to federal research funding. H.R. 3838/S. 2296, National Defense Authorization Act for FY2026, provisions related to conditions for research funding.
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026
Client: COALITION FOR SMARTER REGULATION OF NICOTINE · Firm: DLA PIPER LLP (US)
Center for Tobacco products oversight. FDA oversight. H.R. 4121/S. 2256 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY2026, provisions on tobacco.
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026
Client: COALITION FOR SMARTER REGULATION OF NICOTINE · Firm: DLA PIPER LLP (US)
Center for Tobacco products oversight. FDA oversight. H.R. 4121/S. 2256 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY2026, provisions on tobacco.
Legislative and regulatory proposals affecting intercollegiate athletics. H.R. 4312, SCORE Act. S. 2932, Student Athlete Fairness and Enforcement Act.
Legislative and regulatory proposals affecting intercollegiate athletics. H.R. 4312, SCORE Act. S. 2932, Student Athlete Fairness and Enforcement Act.
Policies and proposals impacting higher education for health sciences. H.R. 5304/S. 2587, Departments of Labor-HHS-Education Appropriations, FY2026, provisions regarding health workforce programming. Federal student aid. H.R. 4312, Student Compensation and Opportunity through Rights and Endorsements Act (SCORE Act).
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026
Client: ASSOCIATION OF AMERICAN UNIVERSITIES · Firm: DLA PIPER LLP (US)
Research security, research funding, and the importance of American research enterprise and higher education. H.R. 5304/S. 2587, Departments of Labor/HHS/Education Appropriations Act, FY2026, provisions on federal research funding. H.R. 3838/S. 2296, National Defense Authorization Act for FY2026, provisions related to conditions for research funding.
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026
Client: ASSOCIATION OF AMERICAN UNIVERSITIES · Firm: DLA PIPER LLP (US)
Research security, research funding, and the importance of American research enterprise and higher education. H.R. 5304/S. 2587, Departments of Labor/HHS/Education Appropriations Act, FY2026, provisions on federal research funding.
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026
Client: UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL · Firm: DLA PIPER LLP (US)
Policies and proposals impacting higher education for health sciences. H.R. 5304/S. 2587, Departments of Labor-HHS-Education Appropriations, FY2026, provisions regarding health workforce programming. Federal student aid.
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026
Client: UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL · Firm: DLA PIPER LLP (US)
Policies and proposals impacting higher education for health sciences. H.R. 5304/S. 2587, Departments of Labor-HHS-Education Appropriations, FY2026, provisions regarding health workforce programming. Federal student aid. H.R. 4312, Student Compensation and Opportunity through Rights and Endorsements Act (SCORE Act).
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026
Client: COALITION FOR SMARTER REGULATION OF NICOTINE · Firm: DLA PIPER LLP (US)
Center for Tobacco products oversight. FDA oversight. H.R. 4121/S. 2256 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY2026, provisions on tobacco.
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026
Client: COALITION FOR SMARTER REGULATION OF NICOTINE · Firm: DLA PIPER LLP (US)
Center for Tobacco products oversight. FDA oversight. H.R. 4121/S. 2256 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY2026, provisions on tobacco.
National Defense Authorization Act for Fiscal Year 2026
Client: ASSOCIATION OF AMERICAN UNIVERSITIES · Firm: DLA PIPER LLP (US)
Research security, research funding, and the importance of American research enterprise and higher education. H.R. 5304/S. 2587, Departments of Labor/HHS/Education Appropriations Act, FY2026, provisions on federal research funding. H.R. 3838/S. 2296, National Defense Authorization Act for FY2026, provisions related to conditions for research funding.
National Defense Authorization Act for Fiscal Year 2026
Client: DUKE UNIVERSITY · Firm: DLA PIPER LLP (US)
Policies and proposals related to federal research funding. H.R. 3838/S. 2296, National Defense Authorization Act for FY2026, provisions related to conditions for research funding.
National Defense Authorization Act for Fiscal Year 2026
Client: DUKE UNIVERSITY · Firm: DLA PIPER LLP (US)
Policies and proposals related to federal research funding. H.R. 3838/S. 2296, National Defense Authorization Act of FY2026, provisions regarding the DETERRENT Act.
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026
Client: UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL · Firm: DLA PIPER LLP (US)
Policies and proposals impacting higher education for health sciences. H.R. 5304/S. 2587, Departments of Labor-HHS-Education Appropriations, FY2026, provisions regarding health workforce programming. Federal student aid.
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026
Client: ASSOCIATION OF AMERICAN UNIVERSITIES · Firm: DLA PIPER LLP (US)
Research security, research funding, and the importance of American research enterprise and higher education. H.R. 5304/S. 2587, Departments of Labor/HHS/Education Appropriations Act, FY2026, provisions on federal research funding. H.R. 3838/S. 2296, National Defense Authorization Act for FY2026, provisions related to conditions for research funding.
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026
Client: ASSOCIATION OF AMERICAN UNIVERSITIES · Firm: DLA PIPER LLP (US)
Research security, research funding, and the importance of American research enterprise and higher education. H.R. 5304/S. 2587, Departments of Labor/HHS/Education Appropriations Act, FY2026, provisions on federal research funding.
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026
Client: UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL · Firm: DLA PIPER LLP (US)
Policies and proposals impacting higher education for health sciences. H.R. 5304/S. 2587, Departments of Labor-HHS-Education Appropriations, FY2026, provisions regarding health workforce programming. Federal student aid. H.R. 4312, Student Compensation and Opportunity through Rights and Endorsements Act (SCORE Act).
Student Athlete Fairness and Enforcement Act
Client: ATLANTIC COAST CONFERENCE · Firm: DLA PIPER LLP (US)
Legislative and regulatory proposals affecting intercollegiate athletics. H.R. 4312, SCORE Act. S. 2932, Student Athlete Fairness and Enforcement Act.
Student Athlete Fairness and Enforcement Act
Client: ATLANTIC COAST CONFERENCE · Firm: DLA PIPER LLP (US)
Legislative and regulatory proposals affecting intercollegiate athletics. H.R. 4312, SCORE Act. S. 2932, Student Athlete Fairness and Enforcement Act.
Issues relating to drug pricing and drug development policies. Pharmacy benefit manager legislation related to patient access to therapies. H.R. 1492/S. 832, EPIC Act. H.R. 1672, MINI Act. Most Favored Nation (MFN) policy.
Issues relating to drug pricing policy. Pharmacy benefit manager legislation related to patient access to therapies. H.R. 1492/S. 832, EPIC Act. H.R. 1672, MINI Act.
Issues relating to drug pricing and drug development policies. Pharmacy benefit manager legislation related to patient access to therapies. H.R. 1492/S. 832, EPIC Act. H.R. 1672, MINI Act. Most Favored Nation (MFN) policy.
Issues relating to drug pricing policy. Pharmacy benefit manager legislation related to patient access to therapies. H.R. 1492/S. 832, EPIC Act.
Ensuring Patient Access to Critical Breakthrough Products Act of 2024
Client: ADVANCED MEDICAL TECHNOLOGY ASSOCIATION (ADVAMED) · Firm: DLA PIPER LLP (US)
Legislative and regulatory proposals and policies regarding medical device innovation. H.R. 2369, Verifying Accurate, Leading-edge IVCT Development (VALID) Act of 2023. H.R. 1691, Ensuring Patient Access to Critical Breakthrough Products Act of 2023.
Ensuring Patient Access to Critical Breakthrough Products Act of 2024
Client: ADVANCED MEDICAL TECHNOLOGY ASSOCIATION (ADVAMED) · Firm: DLA PIPER LLP (US)
Legislative and regulatory proposals and policies regarding medical device innovation. H.R. 2369, Verifying Accurate, Leading-edge IVCT Development (VALID) Act of 2023. H.R. 1691, Ensuring Patient Access to Critical Breakthrough Products Act of 2023. S. 4638, National Defense Authorization Act for FY2025, provisions regarding medical device innovation.
Ensuring Patient Access to Critical Breakthrough Products Act of 2024
Client: ADVANCED MEDICAL TECHNOLOGY ASSOCIATION (ADVAMED) · Firm: DLA PIPER LLP (US)
Legislative and regulatory proposals and policies regarding medical device innovation. H.R. 2369, Verifying Accurate, Leading-edge IVCT Development (VALID) Act of 2023. H.R. 1691, Ensuring Patient Access to Critical Breakthrough Products Act of 2023.
VALID Act of 2023
Client: ADVANCED MEDICAL TECHNOLOGY ASSOCIATION (ADVAMED) · Firm: DLA PIPER LLP (US)
Legislative and regulatory proposals and policies regarding medical device innovation. H.R. 2369, Verifying Accurate, Leading-edge IVCT Development (VALID) Act of 2023. H.R. 1691, Ensuring Patient Access to Critical Breakthrough Products Act of 2023.
VALID Act of 2023
Client: ADVANCED MEDICAL TECHNOLOGY ASSOCIATION (ADVAMED) · Firm: DLA PIPER LLP (US)
Legislative and regulatory proposals and policies regarding medical device innovation. H.R. 2369, Verifying Accurate, Leading-edge IVCT Development (VALID) Act of 2023.
VALID Act of 2023
Client: ADVANCED MEDICAL TECHNOLOGY ASSOCIATION (ADVAMED) · Firm: DLA PIPER LLP (US)
Legislative and regulatory proposals and policies regarding medical device innovation. H.R. 2369, Verifying Accurate, Leading-edge IVCT Development (VALID) Act of 2023. H.R. 1691, Ensuring Patient Access to Critical Breakthrough Products Act of 2023. S. 4638, National Defense Authorization Act for FY2025, provisions regarding medical device innovation.
VALID Act of 2023
Client: ADVANCED MEDICAL TECHNOLOGY ASSOCIATION (ADVAMED) · Firm: DLA PIPER LLP (US)
Legislative and regulatory proposals and policies regarding medical device innovation. H.R. 2369, Verifying Accurate, Leading-edge IVCT Development (VALID) Act of 2023. H.R. 1691, Ensuring Patient Access to Critical Breakthrough Products Act of 2023.
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2025
Client: UNIVERSITY OF ST. AUGUSTINE FOR HEALTH SCIENCES · Firm: DLA PIPER LLP (US)
Policies and proposals impacting higher education for health sciences. H.R. 9029, Labor-HHS-Education Appropriations, FY2025, provisions regarding health workforce programming.
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2025
Client: UNIVERSITY OF ST. AUGUSTINE FOR HEALTH SCIENCES · Firm: DLA PIPER LLP (US)
Policies and proposals impacting higher education for health sciences. H.R. 9029/S. 4942, Labor-HHS-Education Appropriations, FY2025, provisions regarding health workforce programming.
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2025
Client: UNIVERSITY OF ST. AUGUSTINE FOR HEALTH SCIENCES · Firm: DLA PIPER LLP (US)
Policies and proposals impacting higher education for health sciences. H.R. 9029/S. 4942, Labor-HHS-Education Appropriations, FY2025, provisions regarding health workforce programming.
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2025
Client: UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL · Firm: DLA PIPER LLP (US)
Policies and proposals impacting higher education for public research universities. H.R. 9029/S. 4942, Labor-HHS-Education Appropriations, FY2025, provisions regarding Antiviral Drug Discovery (AViDD) Centers for Pathogens of Pandemic Concern.
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2025
Client: UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL · Firm: DLA PIPER LLP (US)
Policies and proposals impacting higher education for public research universities. H.R. 9029, Labor-HHS-Education Appropriations, FY2025, provisions regarding Antiviral Drug Discovery (AViDD) Centers for Pathogens of Pandemic Concern.
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2025
Client: UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL · Firm: DLA PIPER LLP (US)
Policies and proposals impacting higher education for public research universities. H.R. 9029/S. 4942, Labor-HHS-Education Appropriations, FY2025, provisions regarding Antiviral Drug Discovery (AViDD) Centers for Pathogens of Pandemic Concern.
National Defense Authorization Act for Fiscal Year 2025
Client: HUMACYTE, INC. · Firm: DLA PIPER LLP (US)
S. 4921, Department of Defense Appropriations Act, FY2025, provisions related to biologic vascular research. S. 4638, National Defense Authorization Act for FY2025, provisions related to biologic vascular research.
National Defense Authorization Act for Fiscal Year 2025
Client: ADVANCED MEDICAL TECHNOLOGY ASSOCIATION (ADVAMED) · Firm: DLA PIPER LLP (US)
Legislative and regulatory proposals and policies regarding medical device innovation. H.R. 2369, Verifying Accurate, Leading-edge IVCT Development (VALID) Act of 2023. H.R. 1691, Ensuring Patient Access to Critical Breakthrough Products Act of 2023. S. 4638, National Defense Authorization Act for FY2025, provisions regarding medical device innovation.
National Defense Authorization Act for Fiscal Year 2025
Client: HUMACYTE, INC. · Firm: DLA PIPER LLP (US)
S. 4921, Department of Defense Appropriations Act, FY2025, provisions related to biologic vascular research. S. 4638, National Defense Authorization Act for FY2025, provisions related to biologic vascular research.
Department of Defense Appropriations Act, 2025
Client: HUMACYTE, INC. · Firm: DLA PIPER LLP (US)
S. 4921, Department of Defense Appropriations Act, FY2025, provisions related to biologic vascular research. S. 4638, National Defense Authorization Act for FY2025, provisions related to biologic vascular research.
Department of Defense Appropriations Act, 2025
Client: HUMACYTE, INC. · Firm: DLA PIPER LLP (US)
S. 4921, Department of Defense Appropriations Act, FY2025, provisions related to biologic vascular research. S. 4638, National Defense Authorization Act for FY2025, provisions related to biologic vascular research.
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2025
Client: UNIVERSITY OF ST. AUGUSTINE FOR HEALTH SCIENCES · Firm: DLA PIPER LLP (US)
Policies and proposals impacting higher education for health sciences. H.R. 9029/S. 4942, Labor-HHS-Education Appropriations, FY2025, provisions regarding health workforce programming.
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2025
Client: UNIVERSITY OF ST. AUGUSTINE FOR HEALTH SCIENCES · Firm: DLA PIPER LLP (US)
Policies and proposals impacting higher education for health sciences. H.R. 9029/S. 4942, Labor-HHS-Education Appropriations, FY2025, provisions regarding health workforce programming.
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2025
Client: UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL · Firm: DLA PIPER LLP (US)
Policies and proposals impacting higher education for public research universities. H.R. 9029/S. 4942, Labor-HHS-Education Appropriations, FY2025, provisions regarding Antiviral Drug Discovery (AViDD) Centers for Pathogens of Pandemic Concern.
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2025
Client: UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL · Firm: DLA PIPER LLP (US)
Policies and proposals impacting higher education for public research universities. H.R. 9029/S. 4942, Labor-HHS-Education Appropriations, FY2025, provisions regarding Antiviral Drug Discovery (AViDD) Centers for Pathogens of Pandemic Concern.
VALID Act of 2023
Client: ADVANCED MEDICAL TECHNOLOGY ASSOCIATION (ADVAMED) · Firm: DLA PIPER LLP (US)
Legislative and regulatory proposals and policies regarding medical device innovation. H.R. 2369, Verifying Accurate, Leading-edge IVCT Development (VALID) Act of 2023.
2026 · third_quarter · Q3
Policies and proposals impacting higher education for health sciences. H.R. 9260, Departments of Labor-HHS-Education Appropriations, FY2027, provisions regarding health workforce programming. Federal student aid. S. 4668, Protect College Sports Act.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
WAKE FOREST UNIVERSITY via DLA PIPER LLP (US)
2026 · third_quarter · Q3
Policies and proposals related to federal research funding. Federal student aid. S. 4668, Protect College Sports Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
UNITED WAY WORLDWIDE via DLA PIPER LLP (US)
2026 · third_quarter · Q3
Policies and proposals related to disaster relief, housing, healthcare, and childcare.
Policies and proposals related to disaster relief, housing, healthcare, and childcare.
Policies and proposals related to disaster relief, housing, healthcare, and childcare.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
DUKE UNIVERSITY via DLA PIPER LLP (US)
2026 · third_quarter · Q3
Policies and proposals related to federal research funding. H.R. 8800, National Defense Authorization Act for FY2027, provisions related to conditions for research funding. Federal student aid. S. 4668, Protect College Sports Act of 2026. H.R. 9260, Departments of Labor-HHS-Education Appropriations, FY2027, provisions related to conditions for research funding. Federal student aid. Department of Agriculture/FDA Appropriations, FY2027, provisions related to Centers of Excellence funding.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ATLANTIC COAST CONFERENCE via DLA PIPER LLP (US)
2026 · third_quarter · Q3
Legislative and regulatory proposals affecting intercollegiate athletics. H.R. 4312, SCORE Act. S. 2932, Student Athlete Fairness and Enforcement Act. S. 4668, Protect College Sports Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
STAX ENGINEERING, INC. via DLA PIPER LLP (US)
2026 · third_quarter · Q3
S.J. Res. 209, A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Environmental Protection Agency relating to "California State Nonroad Engine Pollution Control Standards; Ocean-Going Vessels At-Berth; Notice of Decision."
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TTX COMPANY via DLA PIPER LLP (US)
2026 · third_quarter · Q3
Policies and proposals related to truck size and weight issues. Surface Transportation Board reauthorization. Polices and proposals related to the railroad industry.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COALITION FOR SMARTER REGULATION OF NICOTINE via DLA PIPER LLP (US)
2026 · third_quarter · Q3
Center for Tobacco products oversight. FDA oversight. H.R. 8646, Department of Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY2027, provisions on tobacco.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, U.S. Trade Representative (USTR)
PGA TOUR via DLA PIPER LLP (US)
2026 · third_quarter · Q3
Tax legislation affecting exempt organizations.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CROWDSTRIKE, INC. via DLA PIPER LLP (US)
2026 · third_quarter · Q3
Policies and proposals related to cybersecurity. H.R. 8800, National Defense Authorization Act, FY 2027, policies and proposals related to cybersecurity.
Filing targets: Defense, Dept of (DOD), Director of National Intelligence (ODNI), HOUSE OF REPRESENTATIVES, SENATE, State, Dept of (DOS)
ADVANCED MEDICAL TECHNOLOGY ASSOCIATION (ADVAMED) via DLA PIPER LLP (US)
2026 · third_quarter · Q3
Legislative and regulatory proposals and policies regarding medical device coverage and reimbursement policies.
Legislative and regulatory proposals and policies regarding medical device innovation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TTX COMPANY via DLA PIPER LLP (US)
2026 · third_quarter · RR
Policies and proposals related to truck size and weight issues; Surface Transportation Board reauthorization; polices and proposals related to the railroad industry.
STAX ENGINEERING, INC. via DLA PIPER LLP (US)
2026 · third_quarter · RR
S.J. Res. 209, A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Environmental Protection Agency relating to "California State Nonroad Engine Pollution Control Standards; Ocean-Going Vessels At-Berth; Notice of Decision"
MICHAELS STORES, INC. via DLA PIPER LLP (US)
2026 · second_quarter · Q2
Policies and proposals related to tariff and trade issues.
Policies and proposals related to tariff and trade issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NOVARTIS via DLA PIPER LLP (US)
2026 · second_quarter · Q2
Tariffs and biotechnology issues related to Treasury and competition with China.
Issues relating to drug pricing and drug development policies. Pharmacy benefit manager legislation related to patient access to therapies. H.R. 1492/S. 832, EPIC Act. H.R. 1672, MINI Act. Most Favored Nation (MFN) policy. Issues related to the 340B program.
Tax reform and tax policy.
BIOGEN, INC. via DLA PIPER LLP (US)
2026 · second_quarter · Q2
Issues related to rare disease and treatment. Drug pricing policy. Public policy around patients' access and affordability. Alzheimer's disease. Issues related to Medicare Part B and D.
Trade-related public policy around tariffs and intellectual property.
Issues related to rare diseases including Alzheimer's disease, Amyotrophic lateral sclerosis (ALS), Lou Gehrig's Disease. Drug pricing and drug development policies. Screening and diagnosis. Patient affordability and access issues, including copay cards, copay accumulators, copay maximizers, coverage issues. Orphan Drug Act. Issues related to the FDA including PDUFA, drug reviews, approval pathways, and clinical trials. Policies related to value based arrangements. Issues related to the 340B program.
MICHAELS STORES, INC. via DLA PIPER LLP (US)
2026 · second_quarter · RR
Policies and proposals related to tariff and trade issues.
Policies and proposals related to tariff and trade issues.
WAKE FOREST UNIVERSITY via DLA PIPER LLP (US)
2026 · second_quarter · Q2
Policies and proposals related to federal research funding. Federal student aid. S. 4668, Protect College Sports Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL via DLA PIPER LLP (US)
2026 · second_quarter · Q2
Policies and proposals impacting higher education for health sciences. H.R. 9260, Departments of Labor-HHS-Education Appropriations, FY2027, provisions regarding health workforce programming. Federal student aid. H.R. 4312, Student Compensation and Opportunity through Rights and Endorsements Act (SCORE Act). S. 4668, Protect College Sports Act.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
UNITED WAY WORLDWIDE via DLA PIPER LLP (US)
2026 · second_quarter · Q2
Policies and proposals related to disaster relief, housing, healthcare, and childcare.
Policies and proposals related to disaster relief, housing, healthcare, and childcare.
Policies and proposals related to disaster relief, housing, healthcare, and childcare.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PGA TOUR via DLA PIPER LLP (US)
2026 · second_quarter · Q2
Tax legislation affecting exempt organizations.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COALITION FOR SMARTER REGULATION OF NICOTINE via DLA PIPER LLP (US)
2026 · second_quarter · Q2
Center for Tobacco products oversight. FDA oversight. H.R. 8646, Department of Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY2027, provisions on tobacco.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, U.S. Trade Representative (USTR)
DUKE UNIVERSITY via DLA PIPER LLP (US)
2026 · second_quarter · Q2
Policies and proposals related to university endowment tax.
Policies and proposals related to federal research funding. H.R. 8800, National Defense Authorization Act for FY2027, provisions related to conditions for research funding. Federal student aid. S. 4668, Protect College Sports Act of 2026. H.R. 9260, Departments of Labor-HHS-Education Appropriations, FY2027, provisions related to conditions for research funding. Federal student aid.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PARTICULA GROUP INC. via DLA PIPER LLP (US)
2026 · second_quarter · Q2
Policy issues related to tokenized assets. H.R. 3633, Digital Asset Market Clarity Act of 2025.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
ADVANCED MEDICAL TECHNOLOGY ASSOCIATION (ADVAMED) via DLA PIPER LLP (US)
2026 · second_quarter · Q2
Legislative and regulatory proposals and policies regarding medical device coverage and reimbursement policies.
Legislative and regulatory proposals and policies regarding medical device innovation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CROWDSTRIKE, INC. via DLA PIPER LLP (US)
2026 · second_quarter · Q2
Policies and proposals related to cybersecurity.
Filing targets: Defense, Dept of (DOD), Director of National Intelligence (ODNI), HOUSE OF REPRESENTATIVES, SENATE, State, Dept of (DOS)
ATLANTIC COAST CONFERENCE via DLA PIPER LLP (US)
2026 · second_quarter · Q2
Legislative and regulatory proposals affecting intercollegiate athletics. H.R. 4312, SCORE Act. S. 2932, Student Athlete Fairness and Enforcement Act. S. 4668, Protect College Sports Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ATLANTIC COAST CONFERENCE via DLA PIPER LLP (US)
2026 · first_quarter · Q1
Legislative and regulatory proposals affecting intercollegiate athletics. H.R. 4312, SCORE Act. S. 2932, Student Athlete Fairness and Enforcement Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NOVARTIS via DLA PIPER LLP (US)
2026 · first_quarter · Q1
Tariffs.
Tax reform and tax policy.
Intellectual property protections and enforcement. Biopharmaceutical patent policy.
BIOGEN, INC. via DLA PIPER LLP (US)
2026 · first_quarter · Q1
Issues related to rare disease and treatment. Drug pricing policy. Issues related to the Medicaid 340B program. Public policy around patients' access and affordability. Alzheimer's disease. Issues related to Medicare Part B and D.
Issues relating to drug pricing policy. Pharmacy benefit manager legislation related to patient access to therapies.
Intellectual property protections and enforcement. Biopharmaceutical patent policy.
ADVANCED MEDICAL TECHNOLOGY ASSOCIATION (ADVAMED) via DLA PIPER LLP (US)
2026 · first_quarter · Q1
Legislative and regulatory proposals and policies regarding medical device innovation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DUKE UNIVERSITY via DLA PIPER LLP (US)
2026 · first_quarter · Q1
Policies and proposals related to federal research funding. National Defense Authorization Act for FY2027, provisions related to conditions for research funding. Federal student aid.
Policies and proposals related to university endowment tax.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CROWDSTRIKE, INC. via DLA PIPER LLP (US)
2026 · first_quarter · Q1
Policies and proposals related to cybersecurity.
Filing targets: Defense, Dept of (DOD), Director of National Intelligence (ODNI), HOUSE OF REPRESENTATIVES, SENATE, State, Dept of (DOS)
ASSOCIATION OF AMERICAN UNIVERSITIES via DLA PIPER LLP (US)
2026 · first_quarter · 1T
Research security, research funding, and the importance of American research enterprise and higher education.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COALITION FOR SMARTER REGULATION OF NICOTINE via DLA PIPER LLP (US)
2026 · first_quarter · Q1
Center for Tobacco products oversight. FDA oversight. Department of Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY2027, provisions on tobacco.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, U.S. Trade Representative (USTR)
PARTICULA GROUP INC. via DLA PIPER LLP (US)
2026 · first_quarter · Q1
Policy issues related to tokenized assets. H.R. 3633, Digital Asset Market Clarity Act of 2025.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HEAD START CALIFORNIA via DLA PIPER LLP (US)
2026 · first_quarter · Q1
Early education issues and Head Start.
Filing targets: HOUSE OF REPRESENTATIVES
UNITED WAY WORLDWIDE via DLA PIPER LLP (US)
2026 · first_quarter · Q1
Policies and proposals related to disaster relief, housing, healthcare, and childcare.
Policies and proposals related to disaster relief, housing, healthcare, and childcare.
Policies and proposals related to disaster relief, housing, healthcare, and childcare.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL via DLA PIPER LLP (US)
2026 · first_quarter · Q1
Policies and proposals impacting higher education for health sciences. Departments of Labor-HHS-Education Appropriations, FY2027, provisions regarding health workforce programming. Federal student aid. H.R. 4312, Student Compensation and Opportunity through Rights and Endorsements Act (SCORE Act).
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
WAKE FOREST UNIVERSITY via DLA PIPER LLP (US)
2026 · first_quarter · Q1
Policies and proposals related to federal research funding. Federal student aid.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PARTICULA GROUP INC. via DLA PIPER LLP (US)
2026 · first_quarter · RA
Policy issues related to tokenized assets.
PARTICULA GROUP INC. via DLA PIPER LLP (US)
2026 · first_quarter · RR
Policy issues related to tokenized assets.
NOVARTIS via DLA PIPER LLP (US)
2025 · fourth_quarter · Q4
Tax reform and tax policy.
Tariffs.
Intellectual property protections and enforcement. Biopharmaceutical patent policy.
ASSOCIATION OF AMERICAN UNIVERSITIES via DLA PIPER LLP (US)
2025 · fourth_quarter · Q4
Research security, research funding, and the importance of American research enterprise and higher education. H.R. 5304/S. 2587, Departments of Labor/HHS/Education Appropriations Act, FY2026, provisions on federal research funding. H.R. 3838/S. 2296, National Defense Authorization Act for FY2026, provisions related to conditions for research funding.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DUKE UNIVERSITY via DLA PIPER LLP (US)
2025 · fourth_quarter · Q4
Policies and proposals related to federal research funding. H.R. 3838/S. 2296, National Defense Authorization Act for FY2026, provisions related to conditions for research funding.
Policies and proposals related to university endowment tax. Federal Student Aid.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL via DLA PIPER LLP (US)
2025 · fourth_quarter · Q4
Policies and proposals impacting higher education for health sciences. H.R. 5304/S. 2587, Departments of Labor-HHS-Education Appropriations, FY2026, provisions regarding health workforce programming. Federal student aid. H.R. 4312, Student Compensation and Opportunity through Rights and Endorsements Act (SCORE Act).
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
CROWDSTRIKE, INC. via DLA PIPER LLP (US)
2025 · fourth_quarter · Q4
Policies and proposals related to cybersecurity.
Filing targets: Defense, Dept of (DOD), Director of National Intelligence (ODNI), HOUSE OF REPRESENTATIVES, SENATE, State, Dept of (DOS)
BIOGEN, INC. via DLA PIPER LLP (US)
2025 · fourth_quarter · Q4
Issues related to rare diseases including Alzheimer's disease, Amyotrophic lateral sclerosis (ALS), Lou Gehrig's Disease. Drug pricing and drug development policies. Screening and diagnosis. Patient affordability and access issues, including copay cards, copay accumulators, copay maximizers, coverage issues. Orphan Drug Act. Issues related to the FDA including PDUFA, drug reviews, approval pathways, and clinical trials. Policies related to value based arrangements.
Issues related to rare disease and treatment. Drug pricing policy. Issues related to the Medicaid 340B program. Public policy around patients' access and affordability. Alzheimer's disease. Issues related to Medicare Part B and D.
COALITION FOR SMARTER REGULATION OF NICOTINE via DLA PIPER LLP (US)
2025 · fourth_quarter · Q4
Center for Tobacco products oversight. FDA oversight. H.R. 4121/S. 2256 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY2026, provisions on tobacco.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ADVANCED MEDICAL TECHNOLOGY ASSOCIATION (ADVAMED) via DLA PIPER LLP (US)
2025 · fourth_quarter · Q4
Legislative and regulatory proposals and policies regarding medical device innovation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DUKE UNIVERSITY HEALTH SYSTEM via DLA PIPER LLP (US)
2025 · fourth_quarter · Q4
Policies and proposals related to coverage and reimbursement, federal government research funding.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HEAD START CALIFORNIA via DLA PIPER LLP (US)
2025 · fourth_quarter · Q4
Early education issues and Head Start.
Filing targets: HOUSE OF REPRESENTATIVES
LAZARUS AI via DLA PIPER LLP (US)
2025 · fourth_quarter · 4T
AI policies and programs within the Department of Defense, the Intelligence Community, and healthcare.
AI policies and programs within the Department of Defense, the Intelligence Community, and healthcare.
AI policies and programs within the Department of Defense, the Intelligence Community, and healthcare.
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE
UNITED WAY WORLDWIDE via DLA PIPER LLP (US)
2025 · fourth_quarter · Q4
Policies and proposals related to disaster relief, housing, healthcare, and childcare.
Policies and proposals related to disaster relief, housing, healthcare, and childcare.
Policies and proposals related to disaster relief, housing, healthcare, and childcare.
Filing targets: Health & Human Services, Dept of (HHS), SENATE
WAKE FOREST UNIVERSITY via DLA PIPER LLP (US)
2025 · fourth_quarter · Q4
Policies and proposals related to federal research funding. Federal student aid.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ATLANTIC COAST CONFERENCE via DLA PIPER LLP (US)
2025 · fourth_quarter · Q4
Legislative and regulatory proposals affecting intercollegiate athletics. H.R. 4312, SCORE Act. S. 2932, Student Athlete Fairness and Enforcement Act.
Filing targets: Education, Dept of, HOUSE OF REPRESENTATIVES, SENATE
UNITED WAY WORLDWIDE via DLA PIPER LLP (US)
2025 · third_quarter · Q3
Policies and proposals related to disaster relief, housing, healthcare, and childcare.
Policies and proposals related to disaster relief, housing, healthcare, and childcare.
Policies and proposals related to disaster relief, housing, healthcare, and childcare.
Filing targets: Health & Human Services, Dept of (HHS), SENATE
CROWDSTRIKE, INC. via DLA PIPER LLP (US)
2025 · third_quarter · Q3
Policies and proposals related to cybersecurity.
Filing targets: Defense, Dept of (DOD), Director of National Intelligence (ODNI), HOUSE OF REPRESENTATIVES, SENATE, State, Dept of (DOS)
ATLANTIC COAST CONFERENCE via DLA PIPER LLP (US)
2025 · third_quarter · Q3
Legislative and regulatory proposals affecting intercollegiate athletics. H.R. 4312, SCORE Act. S. 2932, Student Athlete Fairness and Enforcement Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BIOGEN, INC. via DLA PIPER LLP (US)
2025 · third_quarter · Q3
Issues related to rare diseases including Alzheimer's disease, Amyotrophic lateral sclerosis (ALS), Lou Gehrig's Disease. Drug pricing and drug development policies. Screening and diagnosis. Patient affordability and access issues, including copay cards, copay accumulators, copay maximizers, coverage issues. Orphan Drug Act. Issues related to the FDA including PDUFA, drug reviews, approval pathways, and clinical trials. Policies related to value based arrangements.
Issues related to rare disease and treatment. Drug pricing policy. Issues related to the Medicaid 340B program. Public policy around patients' access and affordability. Alzheimer's disease. Issues related to Medicare Part B and D.
NOVARTIS via DLA PIPER LLP (US)
2025 · third_quarter · Q3
Intellectual property protections and enforcement. Biopharmaceutical patent policy.
Tax reform and tax policy.
Tariffs.
UNITED WAY WORLDWIDE via DLA PIPER LLP (US)
2025 · third_quarter · RR
Policies and proposals related to disaster relief, housing, healthcare, and childcare.
Policies and proposals related to disaster relief, housing, healthcare, and childcare.
Policies and proposals related to disaster relief, housing, healthcare, and childcare.
COALITION FOR SMARTER REGULATION OF NICOTINE via DLA PIPER LLP (US)
2025 · third_quarter · Q3
Center for Tobacco products oversight. FDA oversight. H.R. 4121/S. 2256 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY2026, provisions on tobacco.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL via DLA PIPER LLP (US)
2025 · third_quarter · Q3
Policies and proposals impacting higher education for health sciences. H.R. 5304/S. 2587, Departments of Labor-HHS-Education Appropriations, FY2026, provisions regarding health workforce programming. Federal student aid.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ASSOCIATION OF AMERICAN UNIVERSITIES via DLA PIPER LLP (US)
2025 · third_quarter · Q3
Research security, research funding, and the importance of American research enterprise and higher education. H.R. 5304/S. 2587, Departments of Labor/HHS/Education Appropriations Act, FY2026, provisions on federal research funding.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
LAZARUS AI via DLA PIPER LLP (US)
2025 · third_quarter · Q3
AI policies and programs within the Department of Defense, the Intelligence Community, and healthcare.
AI policies and programs within the Department of Defense, the Intelligence Community, and healthcare.
AI policies and programs within the Department of Defense, the Intelligence Community, and healthcare.
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE
DUKE UNIVERSITY via DLA PIPER LLP (US)
2025 · third_quarter · Q3
Policies and proposals related to federal research funding. H.R. 3838/S. 2296, National Defense Authorization Act of FY2026, provisions regarding the DETERRENT Act.
Policies and proposals related to university endowment tax. H.R. 1, One Big Beautiful Bill Act, university endowment tax. Federal Student Aid.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
WAKE FOREST UNIVERSITY via DLA PIPER LLP (US)
2025 · third_quarter · Q3
Policies and proposals related to federal research funding. H.R. 1, One Big Beautiful Bill Act, federal student aid.
H.R. 1, One Big Beautiful Bill Act, university endowment tax.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DUKE UNIVERSITY HEALTH SYSTEM via DLA PIPER LLP (US)
2025 · third_quarter · Q3
Policies and proposals related to coverage and reimbursement, federal government research funding.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HEAD START CALIFORNIA via DLA PIPER LLP (US)
2025 · third_quarter · Q3
Early education issues and Head Start.
Filing targets: HOUSE OF REPRESENTATIVES
ADVANCED MEDICAL TECHNOLOGY ASSOCIATION (ADVAMED) via DLA PIPER LLP (US)
2025 · third_quarter · Q3
Legislative and regulatory proposals and policies regarding medical device innovation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ASSOCIATION OF AMERICAN UNIVERSITIES via DLA PIPER LLP (US)
2025 · second_quarter · Q2
Research security, research funding, and the importance of American research enterprise and higher education. Departments of Labor/HHS/Education Appropriations Act, FY2026, provisions on federal research funding.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
LAZARUS AI via DLA PIPER LLP (US)
2025 · second_quarter · 2A
AI policies and programs within the Department of Defense, the Intelligence Community, and healthcare.
AI policies and programs within the Department of Defense, the Intelligence Community, and healthcare.
AI policies and programs within the Department of Defense, the Intelligence Community, and healthcare.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DUKE UNIVERSITY via DLA PIPER LLP (US)
2025 · second_quarter · Q2
Policies and proposals related to federal research funding.
Policies and proposals related to university endowment tax. H.R. 1, One Big Beautiful Bill Act, university endowment tax.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL via DLA PIPER LLP (US)
2025 · second_quarter · Q2
Policies and proposals impacting higher education for health sciences. Departments of Labor-HHS-Education Appropriations, FY2026, provisions regarding health workforce programming.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
WAKE FOREST UNIVERSITY via DLA PIPER LLP (US)
2025 · second_quarter · Q2
Policies and proposals related to federal research funding. H.R. 1, One Big Beautiful Bill Act, federal student aid.
H.R. 1, One Big Beautiful Bill Act, university endowment tax.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COALITION FOR SMARTER REGULATION OF NICOTINE via DLA PIPER LLP (US)
2025 · second_quarter · Q2
FDA oversight. FY2026 appropriations.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ATLANTIC COAST CONFERENCE via DLA PIPER LLP (US)
2025 · second_quarter · Q2
Legislative and regulatory proposals affecting intercollegiate athletics.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DUKE UNIVERSITY HEALTH SYSTEM via DLA PIPER LLP (US)
2025 · second_quarter · Q2
Policies and proposals related to coverage and reimbursement, federal government research funding.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ADVANCED MEDICAL TECHNOLOGY ASSOCIATION (ADVAMED) via DLA PIPER LLP (US)
2025 · second_quarter · Q2
Legislative and regulatory proposals and policies regarding medical device innovation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HEAD START CALIFORNIA via DLA PIPER LLP (US)
2025 · second_quarter · Q2
Early education issues and Head Start.
Filing targets: HOUSE OF REPRESENTATIVES
BIOGEN, INC. via DLA PIPER LLP (US)
2025 · second_quarter · Q2
Issues relating to drug pricing policy. Pharmacy benefit manager legislation related to patient access to therapies. H.R. 1492/S. 832, EPIC Act.
Intellectual property protections and enforcement. Biopharmaceutical patent policy.
Issues related to rare diseases including Alzheimer's disease, Amyotrophic lateral sclerosis (ALS), Lou Gehrig's Disease. Drug pricing supply chain. Screening and diagnosis. Patient affordability and access issues, including copay cards, copay accumulators, copay maximizers, coverage issues. Orphan Drug Act. Issues related to the FDA including PDUFA, drug reviews, approval pathways, and clinical trials. Drug pricing. Supply chain issues and gene therapy. Policies related to value based arrangements and implementation of Inflation Reduction Act of 2022.
LAZARUS AI via DLA PIPER LLP (US)
2025 · second_quarter · Q2
AI policies and programs within the Department of Defense, the Intelligence Community, and healthcare.
AI policies and programs within the Department of Defense, the Intelligence Community, and healthcare.
AI policies and programs within the Department of Defense, the Intelligence Community, and healthcare.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NOVARTIS via DLA PIPER LLP (US)
2025 · second_quarter · Q2
Issues relating to drug pricing policy. Pharmacy benefit manager legislation related to patient access to therapies. H.R. 1492/S. 832, EPIC Act. H.R. 1672, MINI Act.
Issues related to rare disease and treatment. Drug and pricing policy. Issues related to the Medicaid 340B program. Public policy around patients' access and affordability. Issues related to Medicare Part B and D.
Intellectual property protections and enforcement. Biopharmaceutical patent policy.
BIOGEN, INC. via DLA PIPER LLP (US)
2025 · second_quarter · RR
Federal proposals and policies impacting disease treatment, including: health care policies; Medicare and Medicaid payment, coverage, and reimbursement; drug pricing and supply chain issues; FDA policies and procedures; drug patents and patent reporting requirements; tariffs; tax reform and tax policy; and intellectual property protections and enforcement.
Federal proposals and policies impacting disease treatment, including: health care policies; Medicare and Medicaid payment, coverage, and reimbursement; drug pricing and supply chain issues; FDA policies and procedures; drug patents and patent reporting requirements; tariffs; tax reform and tax policy; and intellectual property protections and enforcement.
NOVARTIS via DLA PIPER LLP (US)
2025 · second_quarter · RR
Federal proposals and policies impacting disease treatment, including: health care policies; Medicare and Medicaid payment, coverage, and reimbursement; drug pricing and supply chain issues; FDA policies and procedures; drug patents and patent reporting requirements; tariffs; tax reform and tax policy; and intellectual property protections and enforcement.
Federal proposals and policies impacting disease treatment, including: health care policies; Medicare and Medicaid payment, coverage, and reimbursement; drug pricing and supply chain issues; FDA policies and procedures; drug patents and patent reporting requirements; tariffs; tax reform and tax policy; and intellectual property protections and enforcement.
COALITION FOR SMARTER REGULATION OF NICOTINE via DLA PIPER LLP (US)
2025 · second_quarter · RR
FDA regulation and enforcement policies.
FDA regulation and enforcement policies.
FDA regulation and enforcement policies.
ASSOCIATION OF AMERICAN UNIVERSITIES via DLA PIPER LLP (US)
2025 · second_quarter · RR
Research security, research funding, and the importance of American research enterprise and higher education.
ADVANCED MEDICAL TECHNOLOGY ASSOCIATION (ADVAMED) via DLA PIPER LLP (US)
2025 · first_quarter · Q1
Legislative and regulatory proposals and policies regarding medical device innovation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
WAKE FOREST UNIVERSITY via DLA PIPER LLP (US)
2025 · first_quarter · Q1
Policies and proposals related to federal research funding.
Policies and proposals related to university endowment tax.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
LAZARUS AI via DLA PIPER LLP (US)
2025 · first_quarter · Q1
AI policies and programs within the Department of Defense, the Intelligence Community, and healthcare.
AI policies and programs within the Department of Defense, the Intelligence Community, and healthcare.
AI policies and programs within the Department of Defense, the Intelligence Community, and healthcare.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DUKE UNIVERSITY HEALTH SYSTEM via DLA PIPER LLP (US)
2025 · first_quarter · Q1
Policies and proposals related to coverage and reimbursement, federal government research funding.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DUKE UNIVERSITY via DLA PIPER LLP (US)
2025 · first_quarter · Q1
Policies and proposals related to university endowment tax.
Policies and proposals related to federal research funding.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL via DLA PIPER LLP (US)
2025 · first_quarter · Q1
Policies and proposals impacting higher education for health sciences. Labor-HHS-Education Appropriations, FY2025 and FY2026, provisions regarding health workforce programming.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DUKE UNIVERSITY HEALTH SYSTEM via DLA PIPER LLP (US)
2025 · first_quarter · RR
Policies and proposals related to coverage and reimbursement, federal government research funding.
DUKE UNIVERSITY via DLA PIPER LLP (US)
2025 · first_quarter · RR
Policies and proposals related to federal research funding and university endowment tax.
Policies and proposals related to federal research funding and university endowment tax.
WAKE FOREST UNIVERSITY via DLA PIPER LLP (US)
2025 · first_quarter · RR
Policies and proposals related to federal research funding and university endowment tax.
Policies and proposals related to federal research funding and university endowment tax.
ADVANCED MEDICAL TECHNOLOGY ASSOCIATION (ADVAMED) via DLA PIPER LLP (US)
2024 · fourth_quarter · Q4
Legislative and regulatory proposals and policies regarding medical device innovation. H.R. 2369, Verifying Accurate, Leading-edge IVCT Development (VALID) Act of 2023. H.R. 1691, Ensuring Patient Access to Critical Breakthrough Products Act of 2023. S. 4638, National Defense Authorization Act for FY2025, provisions regarding medical device innovation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
LAZARUS AI via DLA PIPER LLP (US)
2024 · fourth_quarter · Q4
AI policies and programs within the Department of Defense, the Intelligence Community, and healthcare.
AI policies and programs within the Department of Defense, the Intelligence Community, and healthcare.
AI policies and programs within the Department of Defense, the Intelligence Community, and healthcare.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Intellectual property protections and enforcement. Biopharmaceutical patent policy.
Issues related to rare disease and treatment. Drug and pricing policies. Public policy around patients' access and affordability. Issues related to Medicare Part B and D.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Issues relating to drug pricing policy. Pharmacy benefit manager legislation related to patient access to therapies.
Intellectual property protections and enforcement. Biopharmaceutical patent policy.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Issues relating to drug pricing and drug development policies. Pharmacy benefit manager legislation related to patient access to therapies. H.R. 1492/S. 832, EPIC Act. H.R. 1672, MINI Act. Most Favored Nation (MFN) policy.
Issues related to rare disease and treatment. Drug and pricing policy. Issues related to the 340B program. Public policy around patients' access and affordability. Issues related to Medicare Part B and D.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Trade-related public policy around tariffs and intellectual property.
Issues related to rare diseases including Alzheimer's disease, Amyotrophic lateral sclerosis (ALS), Lou Gehrig's Disease. Drug pricing and drug development policies. Screening and diagnosis. Patient affordability and access issues, including copay cards, copay accumulators, copay maximizers, coverage issues. Orphan Drug Act. Issues related to the FDA including PDUFA, drug reviews, approval pathways, and clinical trials. Policies related to value based arrangements.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Issues relating to drug pricing and drug development policies. Pharmacy benefit manager legislation related to patient access to therapies. H.R. 1492/S. 832, EPIC Act. H.R. 1672, MINI Act. Most Favored Nation (MFN) policy.
Issues related to rare disease and treatment. Drug and pricing policy. Issues related to the 340B program. Public policy around patients' access and affordability. Issues related to Medicare Part B and D.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Trade-related public policy around tariffs and intellectual property.
Issues relating to drug pricing policy. Pharmacy benefit manager legislation related to patient access to therapies.
Intellectual property protections and enforcement. Biopharmaceutical patent policy.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Issues related to tax reform.
Trade-related public policy around tariffs and intellectual property.
Issues relating to drug pricing policy. Pharmacy benefit manager legislation related to patient access to therapies.
Intellectual property protections and enforcement. Biopharmaceutical patent policy.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Issues relating to drug pricing and drug development policies. Pharmacy benefit manager legislation related to patient access to therapies. H.R. 1492/S. 832, EPIC Act. H.R. 1672, MINI Act. Most Favored Nation (MFN) policy.
Issues related to rare disease and treatment. Drug and pricing policy. Issues related to the 340B program. Public policy around patients' access and affordability. Issues related to Medicare Part B and D.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Issues related to rare disease and treatment. Pricing policy. Issues related to the Medicaid 340B program. Public policy around patients' access and affordability. Alzheimer's disease. Issues related to Medicare Part B and D.
Issues related to tax reform.
Trade-related public policy around tariffs and intellectual property.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Tax reform and tax policy.
Tariffs.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE